Masako Baba

1000 total citations · 1 hit paper
9 papers, 816 citations indexed

About

Masako Baba is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Masako Baba has authored 9 papers receiving a total of 816 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Epidemiology. Recurrent topics in Masako Baba's work include Adipokines, Inflammation, and Metabolic Diseases (3 papers), Peroxisome Proliferator-Activated Receptors (2 papers) and Renal Diseases and Glomerulopathies (2 papers). Masako Baba is often cited by papers focused on Adipokines, Inflammation, and Metabolic Diseases (3 papers), Peroxisome Proliferator-Activated Receptors (2 papers) and Renal Diseases and Glomerulopathies (2 papers). Masako Baba collaborates with scholars based in Japan, United States and Papua New Guinea. Masako Baba's co-authors include Hirofumi Makino, Jun Wada, Jun Eguchi, Izumi Hashimoto, Kenichi Shikata, Kazuyuki Hida, Akihiro Yasuhara, Yashpal S. Kanwar, Shinji Hourai and Eijiro Watanabe and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Diabetes and Biochemical Journal.

In The Last Decade

Masako Baba

9 papers receiving 791 citations

Hit Papers

Visceral adipose tissue-derived serine protease inhibitor... 2005 2026 2012 2019 2005 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masako Baba Japan 6 393 293 187 130 129 9 816
Halil Genç Türkiye 17 557 1.4× 146 0.5× 120 0.6× 214 1.6× 75 0.6× 35 889
Peter F. Bodary United States 20 451 1.1× 454 1.5× 198 1.1× 287 2.2× 233 1.8× 44 1.3k
Neerupma Silswal United States 11 368 0.9× 201 0.7× 256 1.4× 110 0.8× 86 0.7× 19 923
Concetta Di Febbo Italy 18 221 0.6× 176 0.6× 215 1.1× 255 2.0× 59 0.5× 31 1.0k
Hye Kyoung Song South Korea 17 254 0.6× 171 0.6× 213 1.1× 133 1.0× 38 0.3× 19 894
Merja Santaniemi Finland 15 502 1.3× 314 1.1× 182 1.0× 197 1.5× 159 1.2× 22 911
Samy Hadjadj France 16 208 0.5× 172 0.6× 196 1.0× 177 1.4× 55 0.4× 32 808
Mariko Suetsugu Japan 14 262 0.7× 147 0.5× 250 1.3× 124 1.0× 51 0.4× 24 700
Cristiana Bertolani Italy 12 1.0k 2.7× 223 0.8× 265 1.4× 139 1.1× 91 0.7× 15 1.5k
Neşe Ersöz Gülçelik Türkiye 18 263 0.7× 165 0.6× 99 0.5× 101 0.8× 81 0.6× 48 845

Countries citing papers authored by Masako Baba

Since Specialization
Citations

This map shows the geographic impact of Masako Baba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masako Baba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masako Baba more than expected).

Fields of papers citing papers by Masako Baba

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masako Baba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masako Baba. The network helps show where Masako Baba may publish in the future.

Co-authorship network of co-authors of Masako Baba

This figure shows the co-authorship network connecting the top 25 collaborators of Masako Baba. A scholar is included among the top collaborators of Masako Baba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masako Baba. Masako Baba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Baba, Masako, et al.. (2012). Effect of insulin sensitizer, rosiglitazone in streptozotocine induced diabetic db/db mice model. 5(5). 619–623. 1 indexed citations
2.
Hashimoto, Izumi, Jun Wada, Masako Baba, et al.. (2006). Elevated Serum Monocyte Chemoattractant Protein‐4 and Chronic Inflammation in Overweight Subjects. Obesity. 14(5). 799–811. 26 indexed citations
3.
Wada, Jun, Kazuyuki Hida, Jun Eguchi, et al.. (2006). Thiazolidinediones Ameliorate Diabetic Nephropathy via Cell Cycle–Dependent Mechanisms. Diabetes. 55(6). 1666–1677. 87 indexed citations
4.
Eguchi, Jun, Jun Wada, Kazuyuki Hida, et al.. (2005). Identification of adipocyte adhesion molecule (ACAM), a novel CTX gene family, implicated in adipocyte maturation and development of obesity. Biochemical Journal. 387(2). 343–353. 43 indexed citations
5.
Baba, Masako, Jun Wada, Jun Eguchi, et al.. (2005). Galectin-9 Inhibits Glomerular Hypertrophy in db/db Diabetic Mice via Cell-Cycle–Dependent Mechanisms. Journal of the American Society of Nephrology. 16(11). 3222–3234. 33 indexed citations
6.
Hida, Kazuyuki, Jun Wada, Jun Eguchi, et al.. (2005). Visceral adipose tissue-derived serine protease inhibitor: A unique insulin-sensitizing adipocytokine in obesity. Proceedings of the National Academy of Sciences. 102(30). 10610–10615. 572 indexed citations breakdown →
7.
Wada, Jun, Yoshitaka Morita, Masako Baba, et al.. (2004). Multicentric Castleman's disease associated with glomerular microangiopathy and MPGN-like lesion: does vascular endothelial cell-derived growth factor play causative or protective roles in renal injury?. American Journal of Kidney Diseases. 43(1). e1.1–e1.7. 47 indexed citations
8.
Yamaguchi, Toshikazu, et al.. (1991). Pharmacokinetics of Sparfloxacin in Rats, Dogs and Monkeys.. Drug Metabolism and Pharmacokinetics. 6(1). 33–41. 4 indexed citations
9.
Date, Chigusa, Masako Baba, Toyoko Okuda, et al.. (1988). Nutritional status of some Papua New Guinea highlanders as assessed by physical measurements and blood analysis. Ecology of Food and Nutrition. 20(3). 185–196. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026